Read Gene Spolka Akcyjna Logo

Read Gene Spolka Akcyjna

Develops DNA tests to identify genetic cancer risk for early detection and prevention.

RDG | WAR

Overview

Corporate Details

ISIN(s):
PLRADGN00014 (+1 more)
LEI:
2594003D7O7NDUV8GE29
Country:
Poland
Address:
Dobra Grzepnica-Alabastrowa 8, 72-003 Dobra
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Read-Gene S.A. is an innovative biotechnology company focused on the commercialization of methods for the detection, prevention, and treatment of malignant tumors. Established in 2005, the company's core operations are centered on three complementary segments: genetic testing, chemoprevention, and clinical trials. It develops and provides advanced DNA tests that identify genetic predispositions to cancer, enabling precise prophylaxis and facilitating earlier treatment. Additionally, the company offers advisory and support services for oncological genetic counseling centers. Read-Gene is distinguished by its strong scientific foundation, with a team of renowned scientists from the International Hereditary Cancer Center, and holds numerous patents for its novel cancer risk assessment technologies.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-03-25 10:54
Regulatory News Service
Decyzja o ochronie patentowej na wynalazek - Content (PL)
Polish 1.0 KB
2024-03-25 10:51
Regulatory News Service
Decyzja o ochronie patentowej na wynalazek - Content (PL)
Polish 1.1 KB
2023-11-22 16:45
Regulatory News Service
Decyzja o ochronie patentowej na wynalazek - Content (PL)
Polish 1.2 KB
2023-11-16 17:31
Legal Proceedings Report
Decyzja o ochronie patentowej na wynalazek - Content (PL)
Polish 1.2 KB
2023-10-26 16:35
Legal Proceedings Report
Decyzja o ochronie patentowej na wynalazek - Content (PL)
Polish 1.2 KB
2023-08-07 12:11
Regulatory News Service
Decyzja o ochronie patentowej na wynalazek - Content (PL)
Polish 1.4 KB
2023-08-07 12:08
Regulatory News Service
Decyzja o ochronie patentowej na wynalazek - Content (PL)
Polish 1.8 KB
2023-08-07 12:04
Registration Form
Decyzja o ochronie patentowej na wynalazek - Content (PL)
Polish 1.2 KB
2023-08-07 12:01
Regulatory News Service
Decyzja o ochronie patentowej na wynalazek - Content (PL)
Polish 1.2 KB
2023-08-02 13:48
Regulatory News Service
Decyzja o ochronie patentowej na wynalazek - Content (PL)
Polish 1.1 KB
2023-08-02 13:45
Legal Proceedings Report
Decyzja o ochronie patentowej na wynalazek - Content (PL)
Polish 1.2 KB
2023-08-01 15:06
Regulatory News Service
Decyzja o ochronie patentowej na wynalazek - Content (PL)
Polish 1.2 KB
2023-08-01 15:04
Regulatory News Service
Decyzja o ochronie patentowej na wynalazek - Content (PL)
Polish 1.2 KB
2023-06-30 17:30
Declaration of Voting Results & Voting Rights Announcements
Wykaz akcjonariuszy posiadających co najmniej 5% głosów na ZWZ READ-GENE S.A. w…
Polish 584 bytes
2023-06-29 13:27
Director's Dealing
powiadomienie_o_transakcjach_-_zmiana.pdf
Polish 11.9 KB

Automate Your Workflow. Get a real-time feed of all Read Gene Spolka Akcyjna filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Read Gene Spolka Akcyjna

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Read Gene Spolka Akcyjna via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

FARON PHARMACEUTICALS OY Logo
Develops myeloid cell-targeting immunotherapies for solid and hematological cancers.
Finland
FARN
Fluicell AB Logo
Developing bioprinted tissues for regenerative medicine and advanced drug screening.
Sweden
FLUI
FluoGuide A/S Logo
Develops fluorescent drugs to guide surgeons for more precise cancer removal and patient outcomes.
Denmark
FLUO
FUSION ANTIBODIES PLC Logo
A CRO providing end-to-end antibody engineering services for therapeutic & diagnostic development.
United Kingdom
FAB
FUTURA MEDICAL PLC Logo
Develops topical sexual health gels, including a fast-acting, over-the-counter ED treatment.
United Kingdom
FUM
GENINCODE PLC Logo
AI-powered genetic tests for physicians, predicting and preventing cardiovascular disease.
United Kingdom
GENI
Genomic Vision Logo
Develops DNA analysis tools using Molecular Combing for genetic research and diagnostics.
France
GV
Genxone Spolka Akcyjna Logo
A biotech firm offering nanopore DNA/RNA sequencing services and medical diagnostics.
Poland
GX1
Hamlet BioPharma AB Logo
Developing selective therapies for cancer and infections like bladder cancer and UTIs.
Sweden
HAMLET
Hipower Energy Spolka Akcyjna Logo
Develops hydrogen solutions, mobile refueling, and CO2-to-methanol tech for energy markets.
Poland
HPE

Talk to a Data Expert

Have a question? We'll get back to you promptly.